Harmony Biosciences Holdings (HRMY) Return on Capital Employed (2020 - 2026)

Harmony Biosciences Holdings has disclosed Return on Capital Employed across 7 years of filings, most recently posting 0.26% for Q1 2026.

• Return on Capital Employed for Q1 2026 came in at 0.26%, down 2315.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.26% (down 2315.0% YoY), and the FY2025 annual result was 5.11%, down 2102.0% from the prior year.
• Return on Capital Employed came in at 0.26% for Q1 2026 at Harmony Biosciences Holdings, down from 4.57% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 30.44% in Q4 2023 to a low of 0.26% in Q1 2026.
• The 5-year median for Return on Capital Employed is 24.14% (2025), against an average of 22.31%.
• Across the five-year window, Return on Capital Employed surged 1417 bps in 2022 and slumped 2315 bps in 2026, its largest moves.
• Harmony Biosciences Holdings' Return on Capital Employed stood at 20.73% in 2022, then surged by 47 bps to 30.44% in 2023, then fell by 21 bps to 24.2% in 2024, then sank by 81 bps to 4.57% in 2025, then slumped by 106 bps to 0.26% in 2026.
• The last three Return on Capital Employed figures came in at 0.26% (Q1 2026), 4.57% (Q4 2025), and 24.14% (Q3 2025), per Business Quant data.